These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 13039951

  • 1. [Variations in fibrinogenemia, prothrombin time and liquoid coagulation time during treatment with anticoagulants].
    FRANCESCON M, BUTTO M.
    Acta Med Patav; 1952; 13(6):265-88. PubMed ID: 13039951
    [No Abstract] [Full Text] [Related]

  • 2. Studies on the efficiency of vitamin K1 in small doses as antidote against anticoagulants of the dicoumarol type.
    GEILL T, LUND E, DAM H, SØNDERGAARD E.
    Scand J Clin Lab Invest; 1954; 6(3):203-9. PubMed ID: 13205146
    [No Abstract] [Full Text] [Related]

  • 3. [Prothrombin determination in combined treatment with heparin and drugs of the dicumarol type].
    TRONNBERG G.
    Nord Med; 1955 Jun 30; 53(26):1028-9. PubMed ID: 13244879
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of heparin on percentage content of prothrombin; range of variations and their significance in relation to heparin with dicumarol therapy].
    TAGLIACOZZO S.
    Policlinico Chir; 1956 Jun 30; 63(3):141-59. PubMed ID: 13349502
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Control of dicoumarin effect on blood coagulation].
    THIES HA.
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1956 Jun 30; 273():320-2. PubMed ID: 13045631
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Action of lability factor on the effects of sodium salicylate and tromexan on prothrombin time].
    SERT AS.
    Tip Fak Mecm; 1954 Jun 30; 17(3):434-9. PubMed ID: 13226361
    [No Abstract] [Full Text] [Related]

  • 10. Clinical experience with coumarin anticoagulants warfarin and warfarin sodium.
    CLATANOFF DV, TRIGGS PO, MEYER OO.
    AMA Arch Intern Med; 1954 Aug 30; 94(2):213-20. PubMed ID: 13180041
    [No Abstract] [Full Text] [Related]

  • 11. The laboratory control of anticoagulant therapy; factors determining the accuracy of one-stage prothrombin time determinations.
    BLANCHARD EW.
    Am J Med Technol; 1953 Aug 30; 19(4):182-97. PubMed ID: 13065309
    [No Abstract] [Full Text] [Related]

  • 12. Biophysical studies of blood plasma proteins; the effect of fibrinogen on prothrombin time.
    DEUTSCH HF, GERARDE HW.
    J Biol Chem; 1946 Nov 30; 166(1):381-8. PubMed ID: 20273704
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The fibrinogenemia of the newborn].
    SALAZAR DE SOUSA C, CRESPO FERREIRA J, FERREIRA GOMES A, ESTRELA A.
    Arch Fr Pediatr; 1953 Nov 30; 10(5):474-9. PubMed ID: 13081188
    [No Abstract] [Full Text] [Related]

  • 19. [Experimental research on the anticoagulant marcoumar (3-(1-phenyl-propyl)-4-hydroxy-coumarin) and its antagonist konakion (synthetic vitamin K1)].
    JURGENS R.
    Schweiz Med Wochenschr; 1953 May 16; 83(20):471-5. PubMed ID: 13076081
    [No Abstract] [Full Text] [Related]

  • 20. EFFECT OF SUDDEN WITHDRAWAL OF LONG-TERM ANTICOAGULANT THERAPY ON THE HEPARIN RESISTANCE AND PLASMA FIBRINOGEN LEVEL.
    COTTON RC, WADE EG.
    Clin Sci; 1964 Apr 16; 26():337-43. PubMed ID: 14162427
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.